Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety and feasibility of performing
hyperpolarized metabolic MRI in the diagnosis of brain tumor. This study will also assess the
accuracy of hyperpolarized metabolic MRI to diagnose intermediate to patients with
infiltrating gliomas and examine the added utility of metabolic MRI over standard MRI imaging
The FDA is allowing the use of hyperpolarized [1-13C] pyruvate (HP 13C-pyruvate) in this
study.
Up to 5 patients may take part in this study at the University of Maryland, Baltimore (UMB).